Market revenue in 2024 | USD 1,018.9 million |
Market revenue in 2030 | USD 2,010.7 million |
Growth rate | 12% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.39% in 2024. Horizon Databook has segmented the U.S. pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. pancreatic cancer treatment market is highly competitive, led by key players such as AstraZeneca, Novartis AG, and Pfizer Inc., leveraging established therapies and pioneering innovations.
According to the WHO, there were 60,127 new cases in 2022 and over 50,000 deaths each year. Pancreatic cancer ranks as the third leading cause of cancer-related mortality in the U.S., underscoring the demand for effective treatments.
AstraZeneca has made strides with olaparib, a PARP inhibitor for BRCA-mutated cases, while Novartis AG focuses on immunotherapies targeting the tumor microenvironment, and Pfizer Inc.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account